Georgiadis Theofylaktos1, Kourti Areti1, Georgiou Elisavet2, Iliadis Stavros2, Gkeka Ioanna1, Georgiadis Ioannis1 and Makedou Kali1*
Received: April 17, 2023; Published: April 26, 2023
*Corresponding author: Kali Makedou, Laboratory of Biochemistry, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, Greece
DOI: 10.26717/BJSTR.2023.50.007886
Vitamin D, a hormone synthesized in the skin by ultraviolet radiation, is regulating bone metabolism, but has many extra-skeletal actions as well. It has been suggested that vitamin D plays a significant role in the pathophysiology of cardiovascular diseases. Its involvement in anti-inflammatory and antioxidant mechanisms results in an inverse relationship between vitamin D levels and cardiometabolic risk, as shown by observational studies. Randomized controlled studies have shown that vitamin supplementation has decreased inflammatory and oxidative stress biomarkers.
Keywords: Vitamin D; Antioxidant; Cardiovascular
Vitamin D is traditionally known as the hormone involved in calcium and phosphorus metabolism, regulating bone homeostasis and health. However, it has been found to participate in several extraskeletal conditions, like cancer and cardiovascular diseases (CVD). During the last decade, there has been increasing evidence of the consequences of vitamin D deficiency in health, in skeletal and nonskeletal clinical conditions, an issue that is controversial [1]. There are two known forms of vitamin D, vitamin D3 or cholecalciferol produced in the skin after exposure to ultraviolet radiation, and vitamin D2 or ergocalciferol found in plants and fungi. These two forms present certain structural similarities [2]. Cardiovascular diseases (CVD), i.e., hypertension, coronary heart disease, stroke, etc., are a major cause of increased mortality worldwide. Inflammation and oxidative stress seem to play a crucial role in the pathophysiology of CVD. Different researchers have suggested that there is an association between vitamin D deficiency and the onset of CVD, not being able to define the threshold that is the most appropriate for the prevention of CVD [3,4]. There are many mechanisms proposed for the involvement of vitamin D in the pathophysiology of CVD, among which are inflammation and oxidative stress [5]. The aim of the present review is to summarize all the existing data on the role of vitamin D in oxidative stress and CVDs.
Vitamin D Levels and Metabolism
Vitamin D existing in the human body is either synthesized within the skin by ultraviolet radiation (about 90%) or is received by food, like fish (salmon, tuna, etc.), veal liver, egg yolk, mushrooms, shrimps, and cod liver oil. In some counties, the enrichment of certain foods, such as cereals, dairy products, and margarine, with vitamin D is allowed. Vitamin D is absorbed mainly in the duodenum, and in the large intestine [6]. Another source of vitamin D is the dietary supplements received per os, either as multivitamin products containing 400-1000 IU of vitamin D2 or as pure vitamin D3 supplements containing 400- 50,000 IU [7].
Vitamin D is synthesized by photolysis of 7-dihydro-cholesterol by UV radiation (290-315 nm). The first compound synthesized is provitamin D3, which is then transformed into vitamin D3 or cholecalciferol [8]. Vitamin D3 is a pro-hormone, activated by the addition of two hydroxyl groups on the C25 and C1a, producing 1,25(OH)2D3, with the help of the enzymes of the family of cytochrome P450 (CYP) [9]. The first hydroxylation takes place in the liver and 25(OH)vitamin D3 [25(OH)D], the main circulating form of vitamin D, is produced. Bound to an α-globulin, the vitamin D- binding protein (VDBP), 25(OH)vitamin D3 is transferred to the kidneys where a second hydroxylation by 1α-hydroxylase takes place and 1,25(OH)2 vitamin D3 [1,25(OH)2 D3], the most potent vitamin D metabolite, is produced. VDBP binds 25(OH)D with 10-100 higher affinity than that of 1,25(OH)D3 [10].
According to the Endocrine Society, the optimal serum levels are advised to be above 30ng/mL, ideally between 40 and 60 ng/mL. Serum levels between 21 and 29 ng/mL are considered “insufficiency”, levels lower than 20 ng/mL are “deficiency”, and levels less than 10 ng/mL are “extreme deficiency” [7]. However, the Institute of Medicine has reported the threshold of 20 ng/mL for physiologically optimal levels of vitamin D [11]. Intoxication of vitamin D is rarely reported. Increased exposure to the sun cannot result in intoxication if the excess of vitamin D is neutralized within the skin. The only way of intoxication is the consumption of large quantities of vitamin D for a long period of time, resulting in hypercalcemia and/or hypercalciuria and, possibly, kidney stones. On the other hand, insufficiency and deficiency of vitamin D have a high prevalence worldwide nowadays [12].
Vitamin D Biological Action
Vitamin D, like all steroid hormones, acts in the nucleus and on the surface of the cells, like all peptide hormones. Its nuclear receptor, vitamin D receptor (VDR) is connected to both the DNA and the ligand. It has been found in the gut, the bones, the kidneys, and in other organs not related to calcium metabolism, like immune cells, myocardiocytes, and other muscle cells, liver cells, prostate cells, etc. [13]. Vitamin D action on genes is rapid, enhancing the synthesis of proteins like osteocalcin and calcium-binding protein, and downregulating the synthesis of parathormone and cytokines, like IL-17 [14].
The extra-DNA action of vitamin D is exerted via cytoplasmic membrane receptors (1,25 D3-MARRS or PDIA3) and secondary messengers (cAMP and kinases) that affect calcium channels and intracellular calcium concentration. This action takes place in tissues like pancreas, smooth muscle cells, the gut and monocytes, and regulates cell differentiation and function [15]. In small intestine, 1,25(OH)2D3 increases calcium absorbance via increased expression of calcium channels, increased production of proteins, such as alkaline phosphatase and calmodulin, that help calcium enter the circulation [16]. The skeletal actions of vitamin D include increased bone absorption by osteoclasts and increased osteoclasts proliferation. Vitamin D also increases calcium reabsorption in distant renal tubules [17]. All these actions are exerted in response to low calcium serum levels [18,19].
Non-classical actions of 1,25(OH)2D3 include:
i) Regulation of cell proliferation and differentiation,
ii) Strengthening of epidermal barrier,
iii) Anti inflammatory and immune compromising properties,
iv) Role in reproduction, pregnancy, placenta integrity and fetal
growth,
v) Role in the development and proper function of central and
peripheral nervous system,
vi) Appetite reduction,
vii) Regulation of metabolism and endocrine homeostasis,
viii) Regulation of the cardiovascular system [20],
and
ix) Anti-carcinogenic action via genes’ activation or suppression
in all stages of carcinogenesis [21].
Vitamin D and Cardiovascular Diseases
Seasonal changes in blood pressure and the identification of VDR and 1a-hydroxylase in cardiomyocytes, in endothelial and vascular smooth muscle cells, implicate the involvement of vitamin D in cardiovascular diseases. Animal studies have provided proof that vitamin D signaling is necessary for cardiovascular integrity, especially for the regulation of vascular tone, as well as for antifibrotic and anti-hypertrophic signaling in the heart. In specific, researchers have attributed seasonal cardiovascular events to low levels of 25(OH)D that was observed in winter [22]. Although there are many observational studies indicating a correlation between vitamin D deficiency and hypertension, atherosclerosis, and heart failure, they have failed to prove an aetiological relation between vitamin D supplementation and cardiovascular health [23]. Similarly, a study of 25,871 subjects failed to show favorable action of vitamin D on cardiovascular system [24,25].
The VDR, first identified in cardiovascular tissues in 1986 [26], is a member of the transcription factor superfamily of nuclear receptors and translocate to the nucleus regulating the transcription of target genes, after the stimuli of vitamin D [27]. Experimental models have shown that vitamin D has many cardiovascular actions, such as inhibiting hypertrophy, decreasing cardiomyocytes’ proliferation, increasing vascular smooth muscle cells’ proliferation, increasing the expression of vascular endothelial growth factor (VEGF) and inhibiting of the renin-angiotensinaldosterone system (RAAS) and the release of natriuretic peptides [28]. VDR activation by calcitriol or its analogues may directly inhibit the expression of angiotensin I and local production of angiotensin II in cardiomyocytes, in renal arteries and in kidneys [29]. It seems that vitamin D is also involved in the pathophysiology of heart failure by regulating the expression of certain metalloproteinases and metalloproteinases inhibitors [30]. Moreover, vitamin D can also affect the cardiovascular system indirectly, by being involved in the pathophysiology of hypertension, dyslipidemia, and diabetes. Finally, there is increasing evidence implicating an anti-inflammatory role by inhibiting TNF-α and nuclear factor k-B and promoting IL-10 expression in cardiovascular disease [31].
Vitamin D is an Antioxidant and Anti-inflammatory Factor
Epidemiological data have shown a significant contribution of vitamin D to the maintenance of cardiovascular health [32]. The pathophysiology of cardiovascular events includes endothelial dysfunction, vascular injury, inflammation, oxidative stress, thrombosis and, finally, plaque rupture [33] a process enhanced by several modifiable and non-modifiable risk factors, such as obesity, hypertension, and insulin resistance [34,35]. Nitric oxide (NO), apart from being a vasodilation factor and acting as a neurotransmitter, it is a potent antioxidant factor as well. Several studies have shown that vitamin D can stimulate NO production by increasing endothelial NO synthase (eNOS) gene expression [36,37]. Moreover, vitamin D seems to increase the expression of antioxidant enzymes and to up-regulate the intracellular antioxidant pathway of the nuclear factor erythroid 2-related factor 2 [38-40].
Vitamin D seems to reduce chronic inflammation, pathophysiologically involved in endothelial dysfunction, atherosclerosis, and CVD. Its anti-inflammatory actions include down-regulation of NF-kB and STAT1/5-mediated signaling, with subsequent down-regulation of the production of anti-inflammatory cytokines, such as TNF-α, IL-1, IL-2β, etc. [41]. Moreover, binding of vitamin D to VDR results in the decrease of prostaglandin and cyclooxygenase 2 production, reduction of metalloproteinase-9 (MMP-9) and increase in anti-inflammatory IL-10 production [42]. The threshold for vitamin D deficiency is set to favor bone metabolism and health [43]. It is, however, still unknown which levels of vitamin D are the optimal for maintaining cardiovascular health [44]. Randomized controlled trials have shown that vitamin D supplementation improves oxidative and inflammatory biomarkers, such as total antioxidant capacity, C-reactive protein, and glutathione, but has no effect to others like malondialdehyde and carbonyl group levels [43-47]. More studies are needed to address the certain vitamin D status necessary for CVD prevention and for the best cardiovascular benefit.
The involvement of vitamin D in the pathophysiology of CVD has been demonstrated by both observational and epidemiological studies. It seems to be significantly related to its anti-inflammatory and antioxidant properties. Vitamin D deficiency has been shown to be associated with greater CVD risk, but any possible etiological relation must be clarified. Vitamin D supplementation is considered beneficial for the reduction of oxidative and inflammatory parameters and for the prevention of CVD, but the optimal vitamin D status for the maximum cardiovascular benefit needs further investigation.